eCite Digital Repository

Clusterin may be Involved in Rat Liver Allograft Tolerance


Chiang, KC and Goto, S and Chen, CL and Lin, CL and Lin, YC and Pan, TL and Lord, RJ and Lai, CY and Tseng, HP and Hsu, LW and Lee, TH and Yokoyama, H and Kunimatsu, M and Chiang, YC and Hashimoto, T, Clusterin may be Involved in Rat Liver Allograft Tolerance, Transplant Immunology, 8, (2) pp. 95-9. ISSN 0966-3274 (2000) [Refereed Article]

DOI: doi:10.1016/S0966-3274(00)00011-3


Little is known about the possible role of complement inhibitors on tolerance induced by liver allografts. Clusterin, which is a plasma glycoprotein, inhibits cytolytic membrane attack complex (MAC) of complement by binding to soluble C5b-7 complex. The role of clusterin in relation to the naturally achieved tolerance in a rat orthotopic liver transplantation (OLT) has not been investigated before. Here we determined the kinetics of clusterin expression at different post-transplantation time points in a tolerogenic model (DA-PVG) where rejection was naturally overcome without any immunosuppressive drugs in comparison with the syngenic OLT model (DA-DA). Peripheral blood and liver tissues were taken from OLT at various post-operative time points. A strong expression of soluble clusterin was observed on post-transplantation day 7, which occurred at the peak of the rejection in this tolerogenic OLT model. The expression of clusterin remained strong even after tolerance was achieved. The intensity of clusterin expression was much stronger when compared with the syngenic OLT (DA-DA) model after OLT. A strong expression of clusterin mRNA was also observed in the tolerogenic model on post-OLT day (POD) 7 and the expression persisted when compared with the syngenic model on post-OLT day 60. Our data have shown that the strongest levels of clusterin during the reaction phase in tolerogenic OLT may be involved in tolerance induction. (C) 2000 Elsevier Science B.V. All rights reserved.

Item Details

Item Type:Refereed Article
Research Division:Biomedical and Clinical Sciences
Research Group:Immunology
Research Field:Transplantation immunology
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Lord, RJ (Dr Roger Lord)
ID Code:20274
Year Published:2000
Web of Science® Times Cited:7
Deposited By:Surgery
Deposited On:2000-08-01
Last Modified:2001-06-08

Repository Staff Only: item control page